Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microptic is a Barcelona-based diagnostics and medical technology company focused on automated semen analysis and related laboratory systems for assisted reproductive technology and andrology. The company develops and commercializes computer-assisted semen analysis products, including the Sperm Class Analyzer (SCA) CASA System, SCA SCOPE, and SCA Production, along with consumables and software-enabled workflow tools. Its offerings use artificial intelligence and image analysis to assess sperm concentration, motility, morphology, DNA fragmentation, vitality, acrosome reaction, leukocytes, and related parameters. Microptic also offers MetaClass for karyotyping and FISH applications, extending its presence into cytogenetics. The company was acquired by Hamilton Thorne effective November 30, 2022 and continues to operate as part of the broader Nexpring Health fertility-care portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microptic.